What is the scanning of the octreotide?

Octreotide scanning is a medical imaging study conducted to look for symptoms of carcinoid tumors, tumors involving endocrine cells in the body. In this test, a small amount of radioactive tracing material is injected to the patient and several sets of images are taken to monitor the tracker by the body using a camera sensitive. The pictures are read to determine whether cancer is present and collects cancer information if so. This information will be used to develop a treatment plan for the patient's condition. This occurs when the patient's hormones are disrupted and the patient begins to experience the constellation of symptoms such as increment or weight loss, nausea, skin changes, etc. in response to chamfered hormone levels.

In octreotide scanning, the patient reports to the center of nuclear medicine for injection by a technician. The technician usually goes through the patient's history to check any risk factors that could cause a dangerous test. After injection, patients may leave noOr wait in the middle until the stopor has a chance to circulate, so you can buy the first set of pictures. Up to two other sets of images can be obtained during the octreotide scan. The radiologist sums up images and is looking for clusters testifying to carcinoid cells.

The

used terracer, radioactive octreotide, is designed to indicate tumor cells in the body and leave other types of cells in secluded. Clear scanning stains indicate the presence of the stopper and the use of multiple sets of scans allows people to see how quickly the follower accumulates in different places. They can also monitor the movement of the material through the body, local for abnormalities in the way it circulates and distracts the body tissues. The patient will express the material by the kidneys and should not experience complications as a result of the test.

Before scanning Octreotide, patients may be advised to drink a lot of water. This will help them flush the tracing machine when the test is over. Patients who are pregnant or breastfeeding should discuss safety with their obstetricians or pediatricians beforethe procedure of octreotide scan. In general, nursing mothers can feed their infants before the test, express and dispose of milk after a safety test and then restore a regular feed plan.